|
|
|
Insider
Information: |
Loy Bertrand |
Relationship: |
Director |
City: |
Acton |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
345,517 |
|
Indirect Shares
|
420,624 |
|
|
Direct
Value |
$34,725,268 |
|
|
Indirect Value
|
$1,388,059 |
|
|
Total
Shares |
766,141 |
|
|
Total
Value |
$36,113,328 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
0
|
Stock
price went up :
|
7
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
Percentage
Gain/Loss : |
71.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
Harvard Bioscience Inc |
HBIO |
Director |
2023-05-22 |
79,009 |
2023-05-22 |
420,624 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-01-21 |
4 |
AS |
$1.53 |
$6,985 |
D/D |
(4,210) |
264,864 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2011-05-20 |
4/A |
S |
$8.85 |
$92,907 |
D/D |
(10,495) |
268,636 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
18,844 |
269,074 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,300 |
272,426 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2014-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
59,784 |
277,466 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2011-02-22 |
4/A |
S |
$0.00 |
$0 |
D/D |
(31,826) |
279,131 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2011-05-20 |
4 |
S |
$8.85 |
$92,907 |
D/D |
(10,495) |
280,213 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
286,826 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2021-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,401 |
288,227 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2011-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
31,826 |
290,708 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2011-05-16 |
4 |
S |
$8.86 |
$516,696 |
D/D |
(58,333) |
290,708 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,489 |
292,716 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2021-04-13 |
4 |
AS |
$116.56 |
$11,796,079 |
D/D |
(100,000) |
300,906 |
0 |
% |
|
ENTG |
Entegris Inc |
President & CEO |
|
2015-02-19 |
4 |
D |
$13.70 |
$297,276 |
D/D |
(21,699) |
304,810 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2016-02-19 |
4 |
D |
$12.11 |
$213,160 |
D/D |
(17,602) |
307,860 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
324,946 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-12-14 |
4 |
AS |
$5.00 |
$27,000 |
D/D |
(5,400) |
324,946 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-12-15 |
4 |
AS |
$5.00 |
$20,790 |
D/D |
(4,158) |
324,946 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2015-02-19 |
4 |
AS |
$13.48 |
$665,300 |
D/D |
(49,348) |
325,462 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2015-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
65,232 |
326,509 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-12-15 |
4 |
OE |
$4.89 |
$20,333 |
D/D |
4,158 |
329,104 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2011-02-09 |
4 |
S |
$8.70 |
$253,173 |
D/D |
(29,100) |
329,782 |
0 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2009-12-14 |
4 |
OE |
$4.89 |
$26,406 |
D/D |
5,400 |
330,346 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
47,493 |
340,209 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-18 |
4 |
B |
$3.19 |
$3,672 |
D/D |
1,151 |
341,360 |
2.31 |
% |
|
176 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|